Effect of naproxen on proliferation and differentiation of primary cell cultures isolated from human cartilage tissue

Basit Öğe Kaydı
dc.authoridYILMAZ, Ibrahim/0000-0003-2003-6337
dc.authoridYilmaz, Ibrahim/0000-0003-1503-4046
dc.authoridKaraarslan, Numan/0000-0001-5590-0637
dc.contributor.authorKaraarslan, Numan
dc.contributor.authorBatmaz, Ahmet Guray
dc.contributor.authorYılmaz, İbrahim
dc.contributor.authorÖzbek, Hanefi
dc.contributor.authorÇalışkan, Tezcan
dc.contributor.authorŞirin, Duygu Yaşar
dc.contributor.authorKaplan, Necati
dc.date.accessioned2025-03-26T17:34:44Z
dc.date.available2025-03-26T17:34:44Z
dc.date.issued2018
dc.departmentİstanbul Esenyurt Üniversitesi
dc.description.abstractNon-steroidal anti-inflammatory drugs (NSAIDs) that are applied through oral, injectable or topical routes have been widely used in painful and inflammatory musculoskeletal diseases. The current study aimed to determine whether naproxen, an aryl acetic acid derivative with analgesic and anti-inflammatory effects, has a toxic effect on human chondrocytes. Samples containing monolayer primary chondrocyte cultures were prepared following resection from osteochondral tissues obtained from patients with gonarthrosis. Cell viability, toxicity and proliferation and levels of stage-specific embryonic antigen-1, a precursor to human prechondrocytes, were evaluated spectrophotometrically. The results from the untreated control group were compared with those of the study groups, where naproxen was administered in varying doses (1-1,000 mu M). Surface morphologies of the cells were compared using inverted light and environmental scanning electron microscopy. Treatment groups were compared by analysis of variance with Tukey's honest difference post hoc test. P<0.01 was considered to indicate a statistically significant difference. The research revealed significant changes to proliferation and differentiation of chondrocytes in all treatment groups (P<0.01). Naproxen was demonstrated to suppress chondrocyte proliferation and differentiation, which may be an important factor to consider when prescribing this medication to patients.
dc.identifier.doi10.3892/etm.2018.6351
dc.identifier.endpage1654
dc.identifier.issn1792-0981
dc.identifier.issn1792-1015
dc.identifier.issue3
dc.identifier.pmid30186383
dc.identifier.scopus2-s2.0-85051114586
dc.identifier.scopusqualityN/A
dc.identifier.startpage1647
dc.identifier.urihttps://doi.org/10.3892/etm.2018.6351
dc.identifier.urihttps://hdl.handle.net/20.500.14704/873
dc.identifier.volume16
dc.identifier.wosWOS:000443738300011
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpandidos Publ Ltd
dc.relation.ispartofExperimental and Therapeutic Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250326
dc.subjectaryl acetic acid; chondrotoxicity; proliferation; stage-specific embryonic antigen-1
dc.titleEffect of naproxen on proliferation and differentiation of primary cell cultures isolated from human cartilage tissue
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Sağlık Bilimleri Fakültesi Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu